Activation of the PI3K/Akt pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts

Journal of Cellular Biochemistry

Volumn 114, Issue 11, 2013, Pages 2595-2602

  Zhang, Yu ^a   Yang, Jian Hong ^a  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Adipogenic Differentiation; High Glucose; Osteogenic Differentiation; Oxidative Stress; PI3K Akt

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ACETIC ACID DERIVATIVE; ACETYLCYSTEINE; ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; FAT DROPLET; FATTY ACID BINDING PROTEIN 4; GLUCOSE; OSTEOCALCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SCAVENGER; TRANSCRIPTION FACTOR RUNX2;

ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MINERALIZATION; OSTEOBLAST; OXIDATIVE STRESS; PRIORITY JOURNAL; UPREGULATION;

ADIPOGENIC DIFFERENTIATION; HIGH GLUCOSE; OSTEOGENIC DIFFERENTIATION; OXIDATIVE STRESS; PI3K/AKT;

ADIPOGENESIS; ANIMALS; CELLS, CULTURED; GLUCOSE; OSTEOBLASTS; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION;

EID: 84884237242     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24607     Document Type: Article

References (25)

1. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung U, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H,. 2004. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Investig 113: 846-855.
2. Aubin D, Gagnon A, Sorisky A,. 2005. Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture. Int J Obes 29: 1006-1009.
3. Balint E, Szabo P, Marshall C, Sprague S,. 2001. Glucose-induced inhibition of in vitro bone mineralization. Bone 28: 21-28.
4. Botolin S, McCabe LR,. 2006. Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99: 411-424.
5. Botolin S, McCabe LR,. 2007. Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 148: 198-205.
6. Botolin S, Faugere MC, Malluche H, Orth M, Meyer R, McCabe LR,. 2005. Increased bone adiposity and peroxisomal proliferator-activated receptor-γ2 expression in type I diabetic mice. Endocrinology 146: 3622-3631.
7. Cho SW, Yang JY, Her SJ, Choi HJ, Jung JY, Sun HJ, An JH, Cho HY, Kim SW, Park KS, Kim SY, Baek WY, Kim JE, Yim M, Shin CS,. 2011. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice. J Bone Miner Res 26: 1939-1952.
8. Choi EM, Kim YH,. 2008. Hesperetin attenuates the highly reducing sugar-triggered inhibition of osteoblast differentiation. Cell Biol Toxicol 24: 225-231.
9. Chuang CC, Yang RS, Tsai KS, Ho FM, Liu SH,. 2007. Hyperglycemia enhances adipogenic induction of lipid accumulation: involvement of extracellular signal-regulated protein kinase 1/2, phosphoinositide 3-kinase/Akt, and peroxisome proliferator-activated receptor γ signaling. Endocrinology 148: 4267-4275.
10. García-Hernández A, Arzate H, Gil-Chavarría I, Rojo R, Moreno-Fierros L,. 2011. High glucose concentrations alter the biomineralization process in human osteoblastic cells. Bone 50: 276-288.
11. Gopalakrishnan V, Vignesh R, Arunakaran J, Aruldhas M, Srinivasan N,. 2006. Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol 84: 93-101.
12. Hamada Y, Fujii H, Fukagawa M,. 2009a. Role of oxidative stress in diabetic bone disorder. Bone 45: 35-38.
13. Hamada Y, Fujii H, Kitazawa R, Yodoi J, Kitazawa S, Fukagawa M,. 2009b. Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin- induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications. Bone 44: 936-941.
14. Hamann C, Goettsch C, Mettelsiefen J, Henkenjohann V, Rauner M, Hempel U, Bernhardt R, Fratzl-Zelman N, Roschger P, Rammelt S, Günther K, Hofbauer LC,. 2011. Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. Am J Physiol Endocrinol Metab 301: E1220-E1228.
15. Hamann C, Rauner M, Höhna Y, Bernhardt R, Mettelsiefen J, Goettsch C, Günther KP, Stolina M, Han CY, Asuncion FJ, Ominsky MS, Hofbauer LC,. 2013. Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus. J Bone Miner Res 28: 627-638.
16. Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL,. 1999. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARγ2. J Cell Biochem 74: 357-371.
17. Li Y, Liu H, Lv Y, Wang D,. 2012. Effect of insulin on prohibitin in the osteogenic differentiation of rat's mandibular bone marrow stromal cells in high glucose. Shanghai J Stomatol 21: 526-530.
18. Magun R, Burgering B, Coffer P, Pardasani D, Lin Y, Chabot J, Sorisky A,. 1996. Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology 137: 3590-3593.
19. McCabe LR,. 2007. Understanding the pathology and mechanisms of type I diabetic bone loss. J Cell Biochem 102: 1343-1357.
20. Schwartz AV,. 2003. Diabetes mellitus: does it affect bone ? Calcif Tissue Int 73: 515-519.
21. Strotmeyer ES, Cauley JA,. 2007. Diabetes mellitus, bone mineral density, and fracture risk. Curr Opin Endocrinol Diab Obes 14: 429-435.
22. Tomiyama K, Nakata H, Sasa H, Arimura S, Nishio E, Watanabe Y,. 1995. Wortmannin. Biochem Biophys Res Commun 212: 263-269.
23. Wang W, Zhang X, Zheng J, Yang J,. 2010. High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP/protein kinase A/extracellular signal-regulated kinase pathway. Mol Cell Biochem 338: 115-122.
24. Xia X, Serrero G,. 1999. Inhibition of adipose differentiation by phosphatidylinositol 3-kinase inhibitors. J Cell Physiol 178: 9-16.
25. Zhen D, Chen Y, Tang X,. 2010. Metformin reverses the deleterious effects of high glucose on osteoblast function. J Diabetes Complications 24: 334-344.